Member Info for Darwen68

Oldblue.

You are a master of gobbledegook.

Castlepaul

You say clever Trevor "doesn't do things by halves"

And yet he has managed to half the share price and then manage to do it again and again

Castlepaul

You say clever Trevor "doesn't do things by halves"

Although parytec and kirkstall have now been given a zero valuation.

Trevor Brown insists they still have assets including a kettle,a microwave and hat stand.

All of which are available for sale, and they look forward to hearing from potentially up to 73 interested parties.

Sianna

They have given us an update. - " they haven't started looking at any possible RTO yet"

All in good time!!

I expect nothing else nowadays.

Delay after delay.

Kept in the dark.

Smoke and mirrors.

Take your pick.

Couldn't make it up.

Good job the share is suspended.

The board are absolutely clueless.

Orhy.

Doubt the share price will move when we start clinical trial - as this bb keeps reiterating we are "now clinical"

Hopefully price will rise on any potential positive results of the trial and hopefully on any talk of JV or partner agreement to yhe disgust of Vlad.

Means we're about to get 200 RNS's.

Guaranteed !!

JHFH

I think you have wobble your head before you criticise others on having an "obsession" on anything related to hemo.

We got an update.

No free money available for a special dividend.

Nobody is interested in the CX300.

Looking like those who took stock in the 2p placing were diddled.

Shocking performance.

Giveaway sale and a flop.

More disappointment.

The two supposed gems result in a giveaway sale and

Wonder if woodenjohn has updated his £1 billion pound buyout prediction

JHFH.

We will have to agree to disagree (either politely or not).

If a company has a solid product,solid management,solid pathway to progression then they should be able to steamroller the practice of shorting and trading to make it impossible to gain from.

It would seem Vlad and prevail have not managed to accomplish what you have espoused for months of finding JV's,investors and collaborations with the run up to your holy grail of FDA CH.

You say you are "sick to death defending Vlad",probably, the same annoyance many have when they have to criticise him.

Marmite comes to mind.

We didn't agree,and we doubted.

Hemo were offered 2p because that is what the investing people think it is worth at this stage.There is a long long way to go.More money will be needed as if the trial stages

It's a shame Hemogenyx isn't listed on that AIM market.

Least we could understand a bit better why it's got the structure of a jumble sale.

JHFH.

I think you suffer from some form of Stockholm syndrome.

Your defence that Vlad and hemo are overpowered by stu is laughable.

I agree shorters are the bain of small cap companies but if they are viably strong,funded,well managed and garner momentum then shorters shouldn't be able to gain traction.

But guess what.........

AREAL.

Sorry to say I think your post is a little misguided.

You say Vlad will do "anything to get the product to market" - think history suggests he will only do this if he is in control and leads to missed opportunities,ever reducing placings and allows the company to be simply traded.

You also state he is not " money orientated" - which may be true,however being cushioned by an exceptionally well paid finance package and share scheme might make his stance easier.

Give Vald a break.

He's a very busy man.

I hear he runs Birmingham city council in his spare time.